Op-ed Banner

From The Milbank Quarterly

Our Op-Ed section features some of the best minds currently working to improve the public's health. Learn more about our op-ed writers by clicking on their photos.
Read our op-ed writers

Our History

Founded in 1905, the Milbank Memorial Fund is one of the oldest foundations in the countrywith a long tradition of improving policy and practice in health.
Explore our history

Our Mission

The Milbank Memorial Fund is an endowed operating foundation that works to improve the health of populations by connecting leaders and decision makers with the best available evidence and experience.
Learn about the MMF

Latest Publication

Primary Care Transformation

Transforming primary care to be more accessible and effective is essential to improving population health and reducing costs. Our newest report looks at the efforts of the Multi-State Collaborative.
Read the report

Latest MQ Study

Family Planning Cost Benefit

We've known for a while that public investment in family planning pays off. A new Milbank Quarterly study reveals just how cost effective it really is.
Read the study Read the press release

Ronald Bayer Jonathan Cohn Lawrence O. Gostin Sara Rosenbaum David Rosner Joshua M. Sharfstein Gail R. Wilensky
News

"Dear Governor-Elect: Some Health Policy Counsel"

"No health policy is in fact a health policy," writes Christopher Koller, President of the Milbank Memorial Fund, in a new blog post in Health Affairs, in which he offers newly elected governors advice on...

Read more

THE MILBANK QUARTERLY'S IMPACT FACTORS SCORE GOES UP AGAIN—TO 5.391

The 2013 Institute for Scientific Information (ISI) recently adjusted The Milbank Quarterly’s 2013 Impact Factor score—and The Milbank Quarterly now has an impact factor of 5.391. In August, the Quarterly’s impact factor had gone up to 5.061.

Read more

Read more News

Press

WHY HOWARD MARKEL IS OFTEN QUOTED ON EBOLA

Take a look at our “Press” page for the past month and you’ll see that the Editor-in-Chief of The Milbank Quarterly, Howard Markel, MD, PhD, was very much in demand as an expert on epidemics and the social and medical uses of quarantine as it pertained to the current Ebola outbreak in West Africa and the United States. Professor Markel is an acclaimed social and cultural historian of medicine, public health, and epidemics...

Read more

Milbank Quarterly Studies in the News

Family Planning Programs Save Taxpayers Billions of Dollars

This Early View Milbank Quarterly study, written by Jennifer Frost and colleagues at the Guttmacher Institute, looked at the impact and cost savings of family planning services delivered to publically supported individuals.

Read more

More Older Americans Need Help with Daily Activities Than We Thought

Nearly half of elderly Medicare beneficiaries have difficulty performing daily routine activities without assistance, according to a Milbank Quarterly study published in September 2014.

Read more

Read more Press

View From Here

Christopher F. Koller
President of the
Milbank Memorial Fund

SOVALDI REDUX—THE STATES MUDDLE THROUGH

What kind of coverage decisions are states making about Sovaldi, the new Hepatitis C drug that costs $1,000 a pill or up to $168,000 a treatment? The drug presents new hope for patients, but grave risks to Medicaid and state corrections budgets, both of which must pay for care for a disproportionate number of people with Hepatitis C.

To read more ...